SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 76831.75
4.03 (-0.01%)

Filter

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
31	Krishna Institute of Medical Sciences Ltd	Q V PT	33,598 Small Cap	796.15 (-0.48%)	128.88	8.55	11.87	17.04	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
32	Kwality Pharmaceuticals Ltd.	Q V+ PT	2,815 Small Cap	2,715.05 (0.07%)	41.8	8.47	21.70	37.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
33	Wanbury Ltd.	Q V+ PT	1,157 Small Cap	326.50 (-1.42%)	17.5	8.01	10.29	30.27	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
34	RPG Life Sciences Ltd.	Q V+ PT	4,827 Small Cap	2,916.15 (-0.08%)	41.91	7.97	12.70	21.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
35	Metropolis Healthcare Ltd.	Q V PT	11,981 Small Cap	583.50 (1.00%)	63.05	7.92	9.22	2.10	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
36	Fischer Medical Ventures Ltd.	Q V PT	2,464 Small Cap	38.57 (2.44%)	N/A	7.89	96.10	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
37	Fortis Healthcare Ltd.	Q V+ PT	71,140 Mid Cap	939.15 (-0.33%)	308.84	7.71	23.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
38	Dr. Agarwals Health Care Ltd.	Q V PT	15,076 Small Cap	475.55 (0.00%)	113.19	7.44	26.38	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
39	Marksans Pharma Ltd.	Q V+ PT	11,941 Small Cap	264.70 (0.46%)	39.71	7.23	22.06	32.86	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
40	Nephrocare Health Services Ltd.	Q V+ PT	6,853 Small Cap	680.05 (-0.21%)	N/A	7.19	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
41	Dr Agarwals Eye Hospital Ltd.	Q V PT	2,436 Small Cap	5,041.05 (0.00%)	34.75	7.04	17.68	31.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
42	Jubilant Pharmova Ltd.	Q V+ PT	15,582 Small Cap	978.25 (0.00%)	783	6.74	-24.99	-38.93	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
43	Jupiter Life Line Hospitals Ltd.	Q V PT	10,728 Small Cap	328.85 (0.49%)	56.06	6.67	21.03	54.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
44	Concord Biotech Ltd.	Q V PT	13,150 Small Cap	1,256.05 (-0.08%)	50.4	6.52	11.33	1.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
45	Mankind Pharma Ltd.	Q V PT	1,05,357 Mid Cap	2,569.70 (0.73%)	51.71	6.44	13.54	13.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
46	Jagsonpal Pharmaceuticals Ltd.	Q V+ PT	1,511 Small Cap	229.20 (0.00%)	35.08	6.36	11.13	39.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
47	Healthcare Global Enterprises Ltd.	Q V+ PT	10,110 Small Cap	677.15 (0.00%)	693.42	6.3	13.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
48	Innova Captab Ltd.	Q V PT	5,527 Small Cap	965.85 (0.00%)	66.04	6.23	25.90	14.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
49	Wockhardt Ltd.	Q V+ PT	30,311 Small Cap	1,863.95 (-0.08%)	142.31	6.15	4.49	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
50	Glenmark Pharmaceuticals Ltd.	Q V+ PT	61,928 Mid Cap	2,194.65 (0.01%)	45.47	5.89	4.60	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
51	Gufic Biosciences Ltd.	Q V PT	3,826 Small Cap	381.55 (0.00%)	60.59	5.76	16.69	24.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
52	Supriya Lifescience Ltd.	Q V+ PT	6,799 Small Cap	844.80 (0.00%)	32.51	5.68	17.45	18.30	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
53	Sun Pharmaceutical Industries Ltd.	Q V+ PT	4,73,509 Large Cap	1,987.70 (0.72%)	41.25	5.67	11.78	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
54	Ipca Laboratories Ltd.	Q V+ PT	45,090 Mid Cap	1,783.05 (0.33%)	39.81	5.65	7.35	1.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
55	Poly Medicure Ltd.	Q V PT	17,025 Small Cap	1,679.65 (0.00%)	50.67	5.58	19.91	26.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
56	Hester Biosciences Ltd.	Q V PT	2,151 Small Cap	2,528.50 (0.00%)	41.29	5.58	6.98	0.80	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
57	Vimta Labs Ltd.	Q V+ PT	2,620 Small Cap	589.10 (0.46%)	32.89	5.57	14.27	28.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
58	Caplin Point Laboratories Ltd.	Q V PT	19,939 Small Cap	2,631.10 (0.30%)	31.09	5.56	17.55	21.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
59	Suraksha Diagnostic Ltd.	Q V PT	1,300 Small Cap	249.80 (0.04%)	40.4	5.31	9.86	-51.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
60	Sun Pharma Advanced Research Company Ltd.	Q V+ PT	6,974 Small Cap	215.10 (0.09%)	4.49	5.23	49.34	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Fischer Medical	38.57	2.44%
KMC Speciality Hosp.	133	1.95%
Blue Jet Healthcare	585.45	1.61%
Max Healthcare Inst.	1,129.05	1.30%
Syngene Internatl.	418.85	1.18%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Nectar Lifesciences	10.06	-3.45%
Fermenta Biotech	433	-2.48%
Themis Medicare	106.45	-1.48%
Wanbury	326.50	-1.42%
Bliss GVS Pharma	455	-1.30%

News about Top Pharma Companies in India

Jul, 2026

Sun Pharmaceutical Industries informs about press release

Sun Pharmaceutical Industries has informed that it enclosed a copy of the press release titled ‘Sun Pharma Notes Organon Shareholder Approval for Proposed Acquisition,’ which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Supriya Lifescience informs about newspaper advertisement

In terms of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Supriya Lifescience has informed that it enclosed copies of the newspaper advertisement extract for Postal Ballot Notice published in the newspapers, Financial Express (English Language) and Loksatta (Marathi Language).

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Wanbury informs about updates

Further to its letter dated 20th July, 2026, Wanbury has informed that a routine current Good Manufacturing Practices (cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the company's facility at Tanuku, West Godavari District, Andra Pradesh during the period from July 13, 2026 to July 17, 2026. At the conclusion of the inspection, the USFDA has issued a Form 483 with six observations. The Company will respond to these observations to FDA within the stipulated time. The relevant disclosures as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular HO/ 49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are provided in Annexure - I.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Hester Biosciences informs about outcome of AGM

Hester Biosciences has informed that this is in reference to letter dated 18 June 2026 and 8 July 2026, the 39th Annual General Meeting (AGM) was held on Tuesday, 21 July 2026 through Video Conferencing (VC) / Other Audio Visual Means (OAVM), commenced at 10:32 am and concluded at 11:08 am, in accordance with the circular(s) issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India and the businesses transacted at the Annual General Meeting mentioned in the Notice dated 15 May 2026. All the resolutions placed before the members for their approval have been passed with the requisite majority via electronic voting as per the scrutiniser's report dated 21 July 2026. They attached proceedings of the 39th Annual General Meeting of the Company; Voting results of 39th Annual General Meeting of the Company; and Scrutiniser's Report on of 39th Annual General Meeting held on 21 July 2026.

The above information is a part of company's filings submitted to BSE.

Jul, 2026

USFDA conducts cGMP inspection at Wanbury’s Andhra Pradesh facility

At the conclusion of the inspection, the USFDA has issued a Form 483 with six observations

Jul, 2026

Glenmark Pharmaceuticals informs about press release

Glenmark Pharmaceuticals has informed that, Glenmark Specialty S.A. (Glenmark) today announced that U.S. FDA has approved the expanded use of RYALTRIS® (olopatadine hydrochloride and mometasone furoate) Nasal Spray, 665 mcg/25 mcg per spray, for the treatment of symptoms of Seasonal Allergic Rhinitis (SAR) in pediatric patients aged 6 to less than 12 years. With this approval, RYALTRIS® is now approved in the United States for adults and pediatric patients aged 6 years and older, extending this treatment option to a younger pediatric population. The company has attached media release.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Sanofi Consumer Healthcare India Ltd.	10,773 Crore
2	Astrazeneca Pharma India Ltd.	20,420 Crore
3	Torrent Pharmaceuticals Ltd.	1,90,832 Crore
4	Procter & Gamble Health Ltd.	11,257 Crore
5	Rubicon Research Ltd.	25,860 Crore
6	Glaxosmithkline Pharmaceuticals Ltd.	43,202 Crore
7	CORONA Remedies Ltd.	12,807 Crore
8	Laurus Labs Ltd.	92,623 Crore
9	Acutaas Chemicals Ltd.	27,579 Crore
10	Thyrocare Technologies Ltd.	9,287 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	27,813	59,102	38.08	12.45	26.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	5,017	1,90,832	88.21	22.69	45.79	29.04
Lupin Ltd. (M)	Somewhat Good	2,424	1,10,189	20.66	4.92	11.95	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,385	42,278	40.04	9.35	27.05	25.35
Alkem Laboratories Ltd. (M)	Very Good	5,600	67,124	30.72	4.80	22.28	17.86

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,714	92,623	105
Sai Life Sciences Ltd. (S)	Very Good	1,283	27,347	53.73
Torrent Pharmaceuticals Ltd. (L)	Very Good	5,017	1,90,832	39.27
Aurobindo Pharma Ltd. (M)	Very Good	1,543	89,115	38.01
Lupin Ltd. (M)	Somewhat Good	2,424	1,10,189	23.52
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Very Good	1,283	27,347	80.08	10.90	42.11	17.75
Ajanta Pharma Ltd. (M)	Very Good	3,385	42,278	40.04	9.35	27.05	13.54
Mankind Pharma Ltd. (M)	Very Good	2,570	1,05,357	51.71	6.44	32.38	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,106	1,10,523	21.93	4.25	13.45	13.52
Lupin Ltd. (M)	Somewhat Good	2,424	1,10,189	20.66	4.92	11.95	13.02

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Lupin Ltd. (M)	Somewhat Good	2,424	1,10,189	20.66	4.92	11.95	32.37
Abbott India Ltd. (M)	Very Good	27,813	59,102	38.08	12.45	26.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,147	96,063	29.81	2.52	15.31	15.75
Zydus Lifesciences Ltd. (M)	Very Good	1,106	1,10,523	21.93	4.25	13.45	14.72
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,988	4,73,509	41.25	5.67	23.65	14.41

You have 8 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Sun Pharmaceutical Industries informs about press release

Supriya Lifescience informs about newspaper advertisement

Wanbury informs about updates

Hester Biosciences informs about outcome of AGM

USFDA conducts cGMP inspection at Wanbury’s Andhra Pradesh facility

Glenmark Pharmaceuticals informs about press release

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.